Two people covered by plans that look nearly identical on paper — same premium, same deductible, same network — can walk out of the same pharmacy paying wildly different amounts for their prescriptions. The gap rarely has anything to do with the pharmacy itself. It comes down to a document almost nobody reads until they need to: the plan's formulary, the tier it assigns to a given medication, and whether that medication requires a doctor to ask permission before the plan will pay for it at all. None of this is arbitrary — it's a real system with its own logic — but almost no one explains that logic before a patient finds out about it at the counter. Here's how it actually works.

What a Formulary Actually Is

A formulary is simply the list of medications a health plan has agreed to cover, organized by cost tier. Every plan negotiates its own formulary behind the scenes with a pharmacy benefit manager — the intermediary that negotiates drug prices on the plan's behalf and decides which medications get preferred placement. A drug being effective, common, or even the newest option on the market doesn't guarantee it's on the list, or that it's priced the same as a close alternative that treats the same condition. Two medications a doctor considers roughly interchangeable can sit on completely different rungs of the same formulary, and only one of those rungs is cheap.

How Tiers Turn One List Into Different Prices

Once a drug is on the formulary, it's assigned to a tier, and the tier — not the medical importance of the drug — is what mostly decides your cost. Most formularies use some version of this ladder, from cheapest to most expensive:

  • Generic drugs — the lowest tier, and usually chemically identical to their brand-name counterpart at a fraction of the plan's cost.
  • Preferred brand-name drugs — brand medications the plan has negotiated a better deal on, priced above generics but below the next tier.
  • Non-preferred brand-name drugs — brand medications without that negotiated deal, often because a cheaper alternative already exists on the formulary.
  • Specialty drugs — typically injectable, biologic, or otherwise complex medications, carrying the plan's steepest cost share and often their own separate rules.

Climbing that ladder doesn't necessarily track how well a drug works. It mostly tracks the deal the plan struck with whoever makes it — and that deal can change from one plan year to the next even when your prescription doesn't.

Why the Same Condition Can Have a Cheap Option and an Expensive One

Because most common conditions have more than one medication that treats them effectively, a formulary usually offers a choice — a lower-tier option and one or more higher-tier alternatives covering essentially the same ground. A newer version of an existing drug, a different brand built on the same active ingredient, or a close cousin in the same drug class can land on a completely different tier than the one your doctor first reaches for, purely because of negotiated pricing rather than clinical superiority. This is also where biosimilars come in — lower-cost versions of complex biologic drugs, built to work the same way as an original, that plans increasingly favor for exactly this reason. Before assuming a prescription's price is fixed, it's worth asking a pharmacist or doctor whether a lower-tier alternative in the same class exists. Often, one does.

Every plan sorts its covered drugs into cost tiers — the higher the step a drug lands on, the more of the bill is yours.

Prior Authorization: The Extra Step Some Drugs Require

Some medications on a formulary come with a condition attached: prior authorization, meaning the plan won't pay until a doctor's office submits paperwork justifying why that specific drug, at that dose, is medically necessary. It shows up most often on newer, pricier, or more specialized medications — the ones a plan wants a second look at before it starts paying for them regularly.

The process exists for reasons beyond pure cost control: it also nudges prescribing toward options with a longer track record and catches cases where a cheaper, equally effective drug hasn't been tried yet. But the friction is real. A prior authorization request can take days to process, requires a doctor's office to do extra administrative work it doesn't always prioritize, and can leave a patient waiting at the pharmacy counter for a medication that was already prescribed. If a fill gets stuck, calling the doctor's office directly to confirm the request was actually submitted is almost always faster than waiting on hold with the plan.

Step Therapy: Proving the Cheaper Option First

A related requirement, step therapy, asks a patient to try — and fail to get adequate results from — a lower-cost medication before the plan will cover a costlier one for the same condition. It's sometimes called "fail first," and it runs on the same logic as prior authorization: if a less expensive option can do the job, the plan wants that tried before it pays for the alternative. Step therapy isn't usually permanent. If a patient already tried the required first-line drug in the past and it didn't work, that history can often be submitted to skip the step — the plan just needs documentation of it, not a second failed attempt.

What Happens When Your Plan Drops a Drug You're Already Taking

Formularies aren't fixed once a plan year starts, and they're rarely fixed even within one. A plan can move a drug to a higher tier, add a new prior authorization requirement, or remove a drug from the formulary altogether — usually at renewal, but sometimes mid-year when a cheaper alternative becomes available. Plans are generally required to notify affected members before a change takes effect, and many offer a temporary transition supply so a patient isn't cut off mid-prescription while a doctor sorts out next steps. The moment that notice arrives is the moment to act, not the moment the next refill gets rejected at the counter — asking the doctor about the covered alternative early avoids a scramble later.

When a Drug Isn't Covered or Gets Denied — What to Actually Do

  • Ask the pharmacist first. They can usually see the formulary in real time and flag a covered alternative faster than anyone else in the chain.
  • Ask the doctor to request a formulary exception. If no lower-tier alternative works for a specific patient, a doctor can ask the plan to cover a higher-tier drug at a lower-tier cost, with medical documentation attached.
  • Appeal a prior authorization denial in writing. Every plan has a formal appeals process, and a documented history of why alternatives failed or aren't appropriate is the strongest evidence in that appeal.
  • Ask about manufacturer assistance. Some drug manufacturers offer their own assistance programs for patients who don't qualify for coverage at all, independent of the insurance formulary.

None of these routes are guaranteed, but all of them beat paying full price at the counter without asking a single question first.

The bottom lineA formulary decides which drugs a plan covers; a tier decides how much of the bill lands on you; prior authorization and step therapy are the plan's way of double-checking that a cheaper option wasn't skipped first. None of it is about whether a drug works — it's about the deal behind it. Ask about tier placement before assuming a price is fixed, and you'll often find a cheaper way to the same result.

None of this requires memorizing your plan's entire formulary. The next time a prescription rings up higher than expected, you'll know exactly which lever moved — the tier, the authorization, or the alternative nobody mentioned — and exactly who to ask about it.